BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 26678349)

  • 1. Postoperative complications and overall survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Pugalenthi A; Protic M; Gonen M; Kingham TP; Angelica MI; Dematteo RP; Fong Y; Jarnagin WR; Allen PJ
    J Surg Oncol; 2016 Feb; 113(2):188-93. PubMed ID: 26678349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe Jaundice Increases Early Severe Morbidity and Decreases Long-Term Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma.
    Sauvanet A; Boher JM; Paye F; Bachellier P; Sa Cuhna A; Le Treut YP; Adham M; Mabrut JY; Chiche L; Delpero JR;
    J Am Coll Surg; 2015 Aug; 221(2):380-9. PubMed ID: 26206638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thrombosis following pancreaticoduodenectomy with venous resection.
    Mohammed S; Mendez-Reyes JE; McElhany A; Gonzales-Luna D; Van Buren G; Bland DS; Villafane-Ferriol N; Pierzynski JA; West CA; Silberfein EJ; Fisher WE
    J Surg Res; 2018 Aug; 228():271-280. PubMed ID: 29907222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
    Lubrano J; Bachelier P; Paye F; Le Treut YP; Chiche L; Sa-Cunha A; Turrini O; Menahem B; Launoy G; Delpero JR
    Eur J Surg Oncol; 2018 Jul; 44(7):1078-1082. PubMed ID: 29685757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of pancreatic fistula and postoperative complications after pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma.
    Neeman U; Lahat G; Goykhman Y; Geva R; Peles-Avraham S; Nachmany I; Nakache R; Klausner JM; Lubezky N
    Surgeon; 2020 Feb; 18(1):24-30. PubMed ID: 31466841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience).
    El Nakeeb A; El Shobary M; El Dosoky M; Nabeh A; El Sorogy M; El Eneen AA; abu Zeid M; Elwahab MA
    Hepatogastroenterology; 2014; 61(133):1426-38. PubMed ID: 25436321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior Mesenteric Artery Margin of Posttherapy Pancreaticoduodenectomy and Prognosis in Patients With Pancreatic Ductal Adenocarcinoma.
    Liu L; Katz MH; Lee SM; Fischer LK; Prakash L; Parker N; Wang H; Varadhachary GR; Wolff RA; Lee JE; Pisters PW; Maitra A; Fleming JB; Estrella J; Rashid A; Wang H
    Am J Surg Pathol; 2015 Oct; 39(10):1395-403. PubMed ID: 26200098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and Predictors of Postoperative Morbidity and Mortality After Pancreaticoduodenectomy for Pancreatic Neuroendocrine Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma.
    Partelli S; Tamburrino D; Cherif R; Muffatti F; Moggia E; Gaujoux S; Sauvanet A; Falconi M; Fusai G
    Pancreas; 2019 Apr; 48(4):504-509. PubMed ID: 30946244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and pathologic features influencing survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Weber CE; Bock EA; Hurtuk MG; Abood GJ; Pickleman J; Shoup M; Aranha GV
    J Gastrointest Surg; 2014 Feb; 18(2):340-7. PubMed ID: 24272772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Results of Pancreatic Resections and Long-Term Survival for Pancreatic Ductal Adenocarcinoma: A Single-Institution Experience.
    Seppänen H; Juuti A; Mustonen H; Haapamäki C; Nordling S; Carpelan-Holmström M; Sirén J; Luettges J; Haglund C; Kiviluoto T
    Scand J Surg; 2017 Mar; 106(1):54-61. PubMed ID: 27130378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model to predict survival following pancreaticoduodenectomy for malignancy based on tumour site, stage and lymph node ratio.
    Dasari BV; Roberts KJ; Hodson J; Stevens L; Smith AM; Hubscher SG; Isaac J; Muiesan P; Sutcliffe RP; Marudanayagam R; Mirza DF
    HPB (Oxford); 2016 Apr; 18(4):332-8. PubMed ID: 27037202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pancreatic leaks on survival following pancreaticoduodenectomy.
    Ausania F; Cook N; Jamieson N; Huguet E; Jah A; Praseedom R
    JOP; 2010 May; 11(3):226-9. PubMed ID: 20442516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended pancreatoduodenectomy as defined by the International Study Group for Pancreatic Surgery is associated with worse survival but not with increased morbidity.
    De Reuver PR; Mittal A; Neale M; Gill AJ; Samra JS
    Surgery; 2015 Jul; 158(1):183-90. PubMed ID: 25920909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Assifi MM; Zhang S; Leiby BE; Pequignot EC; Xia B; Rosato E; Lavu H; Kennedy EP; Yeo CJ; Berger AC
    J Am Coll Surg; 2013 Oct; 217(4):621-7. PubMed ID: 23810574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreaticoduodenectomy is justified in a subset of elderly patients with pancreatic ductal adenocarcinoma: A population-based retrospective cohort study of 4,283 patients.
    Lu L; Zhang X; Tang G; Shang Y; Liu P; Wei Y; Gong P; Ma L
    Int J Surg; 2018 May; 53():262-268. PubMed ID: 29604352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?
    Marsoner K; Langeder R; Csengeri D; Sodeck G; Mischinger HJ; Kornprat P
    Wien Klin Wochenschr; 2016 Aug; 128(15-16):566-72. PubMed ID: 27363995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing outcome in patients undergoing portal vein resection for adenocarcinoma of the pancreas.
    Banz VM; Croagh D; Coldham C; Tanière P; Buckels J; Isaac J; Mayer D; Muiesan P; Bramhall S; Mirza DF
    Eur J Surg Oncol; 2012 Jan; 38(1):72-9. PubMed ID: 22054617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postoperative infectious complications worsen oncologic outcomes following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Khachfe HH; Hammad AY; AlMasri S; Nassour I; ElAsmar R; Liu H; de Silva A; Kraftician J; Lee KK; Zureikat AH; Paniccia A
    J Surg Oncol; 2024 May; 129(6):1097-1105. PubMed ID: 38316936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Multidetector CT Diagnosis of Extrapancreatic Perineural or Duodenal Invasion Is Associated with Reduced Postoperative Survival after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Preliminary Experience and Implications for Patient Care.
    Chang ST; Jeffrey RB; Patel BN; DiMaio MA; Rosenberg J; Willmann JK; Olcott EW
    Radiology; 2016 Dec; 281(3):816-825. PubMed ID: 27438167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.